PTN and cancer: Disrupting the ligand-receptor interaction (Ptn-Ncl), transcriptional regulation (Ybx1), or cytoskeletal dynamics (Stmn1) presents several avenues to reduce cancer cell motility, invasiveness, and metastasis.